Management of Hepatitis C Infection
Summary
- Advanced fibrosis/cirrhosis is associated with reduced likelihood of SVR, including to DAA therapy
- IL28B genotype is associated with interferon responsiveness and SVR to interferon-based therapy[Ge 2009; Tanaka 2009; Thomas 2009]
- Higher IP-10 serum levels, higher BMI, and/or presence of insulin resistance are associated with treatment nonresponse in patients receiving interferon-based therapy[Lagging 2006; Diago 2006; Romero 2006]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Hepatitis C-Prognosis, Hepatitis C-Treatment